Co-expression of CD3 and CD56 molecules has been revealed by us to define the TR3-56 regulatory T cell subset, preferentially involved in the control of cytotoxic T cell effectors in autoimmunity [14] as well as in haematologic disorders [16,17,18]. This evidence concerns the gene NCAM1 and hematologic disorder.